DiaGenic ASA Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	29
ISBN Number	not applicable
Product Code	GMD04681

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a DiaGenic ASA's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook In Vitro Diagnostics
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 Competitors
5 Key Employees
6 Key Employee Biographies
7 Company Statement
8 Locations And Subsidiaries
- 8.1 Head Office
9 Recent Developments
- 9.1 Financial Announcements
  - 9.1.1 Apr 29, 2008: DiaGenic Reports Q1 2008 Results
  - 9.1.2 Feb 14, 2008: DiaGenic Reports Q4 2007 Results
  - 9.1.3 Oct 25, 2007: DiaGenic Reports Q3 2007 Results
  - 9.1.4 Aug 15, 2007: DiaGenic Reports Q2 2007 Results
  - 9.1.5 Apr 25, 2007: DiaGenic Reports Q1 2007 Results
  - 9.1.6 Feb 15, 2007: DiaGenic Reports Q4 2006 Results
- 9.2 Product News
  - 9.2.1 May 23, 2008: DiaGenic Appoints SRL RANBAXY Pathology Laboratories For Marketing DiaGenic's Early Breast Cancer Test In India
  - 9.2.2 Feb 04, 2008: Diagenic Announces Preliminary Results From A Multicenter Breast Cancer Study In India
- 9.3 Clinical Trials
  - 9.3.1 Feb 04, 2008: Diagenic Announces Preliminary Results From A Multicenter Breast Cancer Study In India
10 DiaGenic ASA Pipeline Products
- 10.1 DiaGenic ASA Product Pipeline Analysis
  - 10.1.1 DiaGenic ASA Pipeline Products By Equipment Type
  - 10.1.2 DiaGenic ASA Pipeline Products By Development Stage
  - 10.1.3 DiaGenic ASA Pipeline Products By Therapy Area
  - 10.1.4 DiaGenic ASA Pipeline Products By Clinical Trials
  - 10.1.5 DiaGenic ASA Pipeline Products By News Summary
- 10.2 Signature Test
  - 10.2.1 Product Description
  - 10.2.2 Product Status
- 10.3 DiaGenic breast cancer blood test
  - 10.3.1 Product Description
  - 10.3.2 Product Status
  - 10.3.3 Clinical Trials
  - 10.3.4 Product Milestone
- 10.4 Blood test for Parkinsons disease
  - 10.4.1 Product Description
  - 10.4.2 Product Status
11 Appendix
- 11.1 Methodology
  - 11.1.1 Coverage
  - 11.1.2 Secondary Research
  - 11.1.3 Primary Research
  - 11.1.4 Expert Panel Validation
- 11.2 Contact Us
- 11.3 About Global Markets Direct
- 11.4 Disclaimer
1 List of Tables
- Table 1: DiaGenic ASA,Key Facts
- Table 2: DiaGenic ASA, Key Employees,
- Table 3: DiaGenic ASA Pipeline Products by Equipment Type
- Table 4: DiaGenic ASA Pipeline Products By Development Stage
- Table 5: DiaGenic ASA Pipeline Products By Therapy Area
- Table 6: DiaGenic ASA Pipeline Products By Clinical Trials
- Table 7: DiaGenic ASA Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: DiaGenic ASA Pipeline Products By Development Stage
- Figure 2: Global Markets Direct Methodology